M0324
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for M0324, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors [Phase 1]